BACKGROUND: Single-centered studies show increased number of acute pancreatitis (AP) in children. Here, the Pediatric Section of the Hungarian Pancreatic Study Group introduces an international observational clinical trial (APPLE) to collect a critical mass of clinical data and biomedical research samples in a uniform prospective manner. SUMMARY: The APPLE-R is for patients under 18 years of age with a history of pancreatitis. The study primarily provides information on possible genetic variants behind the disease and their impact on the prognosis. The APPLE-P is for patients under 18 years of age with a diagnosis of AP. Children with AP diagnosed based on the fulfillment of '2 out of 3' of the Atlanta criteria will be selected. This subtrial requests detailed information from the medical history, etiology, complains and symptoms, physical examinations, laboratory parameters, imaging, immediate therapy at admission and complications of the disease. The APPLE trial has been registered at the ISRCTN registry and has received the relevant ethical approval. The study is open for all pediatric centers throughout the world. KEY MESSAGE: This is the first worldwide study tracking earlier (APPLE-R) and ongoing episodes (APPLE-P) of pancreatitis.
BACKGROUND: Single-centered studies show increased number of acute pancreatitis (AP) in children. Here, the Pediatric Section of the Hungarian Pancreatic Study Group introduces an international observational clinical trial (APPLE) to collect a critical mass of clinical data and biomedical research samples in a uniform prospective manner. SUMMARY: The APPLE-R is for patients under 18 years of age with a history of pancreatitis. The study primarily provides information on possible genetic variants behind the disease and their impact on the prognosis. The APPLE-P is for patients under 18 years of age with a diagnosis of AP. Children with AP diagnosed based on the fulfillment of '2 out of 3' of the Atlanta criteria will be selected. This subtrial requests detailed information from the medical history, etiology, complains and symptoms, physical examinations, laboratory parameters, imaging, immediate therapy at admission and complications of the disease. The APPLE trial has been registered at the ISRCTN registry and has received the relevant ethical approval. The study is open for all pediatric centers throughout the world. KEY MESSAGE: This is the first worldwide study tracking earlier (APPLE-R) and ongoing episodes (APPLE-P) of pancreatitis.
Authors: Andrea Szentesi; Emese Tóth; Emese Bálint; Júlia Fanczal; Tamara Madácsy; Dorottya Laczkó; Imre Ignáth; Anita Balázs; Petra Pallagi; József Maléth; Zoltán Rakonczay; Balázs Kui; Dóra Illés; Katalin Márta; Ágnes Blaskó; Alexandra Demcsák; Andrea Párniczky; Gabriella Pár; Szilárd Gódi; Dóra Mosztbacher; Ákos Szücs; Adrienn Halász; Ferenc Izbéki; Nelli Farkas; Péter Hegyi Journal: PLoS One Date: 2016-10-24 Impact factor: 3.240
Authors: Dóra Mosztbacher; Nelli Farkas; Margit Solymár; Gabriella Pár; Judit Bajor; Ákos Szűcs; József Czimmer; Katalin Márta; Alexandra Mikó; Zoltán Rumbus; Péter Varjú; Péter Hegyi; Andrea Párniczky Journal: World J Gastroenterol Date: 2017-02-14 Impact factor: 5.742
Authors: Dezső Kelemen; Péter Hegyi; Levente Pál Kucserik; Katalin Márta; Áron Vincze; György Lázár; László Czakó; Zsolt Szentkereszty; Mária Papp; Károly Palatka; Ferenc Izbéki; Áron Altorjay; Imola Török; Sorin Barbu; Marcel Tantau; András Vereczkei; Lajos Bogár; Márton Dénes; Imola Németh; Andrea Szentesi; Noémi Zádori; Judit Antal; Markus M Lerch; John Neoptolemos; Miklós Sahin-Tóth; Ole H Petersen Journal: BMJ Open Date: 2019-07-09 Impact factor: 2.692
Authors: Balázs Koncz; Erika Darvasi; Dalma Erdősi; Andrea Szentesi; Katalin Márta; Bálint Erőss; Dániel Pécsi; Zoltán Gyöngyi; János Girán; Nelli Farkas; Maria Papp; Eszter Fehér; Zsuzsanna Vitális; Tamás Janka; Áron Vincze; Ferenc Izbéki; Veronika Dunás-Varga; László Gajdán; Imola Török; Sándor Károly; Judit Antal; Noémi Zádori; Markus M Lerch; John Neoptolemos; Miklós Sahin-Tóth; Ole H Petersen; Péter Hegyi Journal: BMJ Open Date: 2020-01-06 Impact factor: 2.692
Authors: Andrea Párniczky; Péter Hegyi; Klementina Ocskay; Márk Félix Juhász; Nelli Farkas; Noémi Zádori; Lajos Szakó; Zsolt Szakács; Andrea Szentesi; Bálint Erőss; Emőke Miklós; Antal Zemplényi; Béla Birkás; Árpád Csathó; István Hartung; Tamás Nagy; László Czopf; Ferenc Izbéki; László Gajdán; Mária Papp; László Czakó; Dóra Illés; Marco V Marino; Antonello Mirabella; Ewa Małecka-Panas; Hubert Zatorski; Yaroslav Susak; Kristina Opalchuk; Gabriele Capurso; Laura Apadula; Cristian Gheorghe; Ionut Adrian Saizu; Ole H Petersen; Enrique de-Madaria; Jonas Rosendahl Journal: BMJ Open Date: 2022-01-04 Impact factor: 2.692
Authors: Katalin Márta; Anikó N Szabó; Dániel Pécsi; Péter Varjú; Judit Bajor; Szilárd Gódi; Patrícia Sarlós; Alexandra Mikó; Kata Szemes; Mária Papp; Tamás Tornai; Áron Vincze; Zsolt Márton; Patrícia A Vincze; Erzsébet Lankó; Andrea Szentesi; Tímea Molnár; Roland Hágendorn; Nándor Faluhelyi; István Battyáni; Dezső Kelemen; Róbert Papp; Attila Miseta; Zsófia Verzár; Markus M Lerch; John P Neoptolemos; Miklós Sahin-Tóth; Ole H Petersen; Péter Hegyi Journal: BMJ Open Date: 2017-09-14 Impact factor: 2.692
Authors: Andrea Szentesi; Andrea Párniczky; Áron Vincze; Judit Bajor; Szilárd Gódi; Patricia Sarlós; Noémi Gede; Ferenc Izbéki; Adrienn Halász; Katalin Márta; Dalma Dobszai; Imola Török; Hunor Farkas; Mária Papp; Márta Varga; József Hamvas; János Novák; Artautas Mickevicius; Elena Ramirez Maldonado; Ville Sallinen; Dóra Illés; Balázs Kui; Bálint Erőss; László Czakó; Tamás Takács; Péter Hegyi Journal: Front Physiol Date: 2019-09-20 Impact factor: 4.566